Real-time selective sequencing of individual DNA fragments, or 'Read Until', allows the focusing of Oxford Nanopore Technology sequencing on pre-selected genomic regions.
Introduction

1
Nanopore sequencing (commercially available from Oxford Nanopore Technologies, 2 ONT) enables fast, portable and cheap long-read sequencing [1, 2] . It has a number of 3 fundamental differences to the sequencing-by-synthesis approaches due to its entirely 4 different sensing approach of detecting the sequence of DNA or RNA (and other small 5 analytes) as they translocate through a small pore (nanopore). By maintaining a 6 voltage difference across the nanopore and detecting changes in ionic current the nature 7 of the analyte can be determined. The progression of nucleic acid through the pore is 8 controlled by a motor protein ensuring enough readings can be taken to permit 9 deconvolution of the contributions of all nucleic acids to the current signal. This 10 mechanism does not change along the nucleic acid polymer, meaning that read length is 11 determined by sample preparation and the ability to deliver the sample to the pore, and 12 can be extremely large [1, 3] . As the change in current is specific to the precise 13 chemistry of the bases in the pore, the sequence of the nucleic acid polymer can be amplicons or removing off target sequences [5] [6] [7] [8] . These developments have sparked 23 interest in technological, mathematical and algorithmic methods for optimizing the 24 decision framework for which fragments should be prioritized in Read Until [6, 9, 10] . 25 Here, we propose new techniques that expand the potential and applicability of ONT 26 and Read Until by 27 • increasing the confidence in the reconstructed genome (reducing the number of 28 genome inference errors),
29
• compensating for coverage fluctuations along the genome due to amplification and 30 sequencing biases or random chance, and deliver a more uniform coverage while 31 increasing the minimum coverage achieved, and
32
• focusing sequencing efforts on regions that are a posteriori, but not a priori, more 33 important, for example identifying regions with indels and rearrangements that 34 could cause subsequent assembly difficulties or be more biologically interesting.
35
To achieve this, we introduce a mathematical and algorithmic framework for quantifying 36 the expected value of DNA fragment reads of which only a small initial portion has 37 already been sequenced. We propose a decision strategy that rejects reads that are not 38 deemed sufficiently valuable, while accounting for the expected value of future reads and 39 the costs of the decision-making process, rejection of low-value fragments and 40 acquisition of new ones. We prove that our strategy is optimal in terms of capturing the 41 most value at any given moment in the sequencing experiment and, finally, we illustrate 42 the use and advantages of our strategy in a number of realistic scenarios.
Materials and Methods
44
There are two components to this work. The first is the definition of an objective 45 function to quantify the value of a read, while considering possible regions of interest in 46 the genome and considering sample preparation as well as all the sequencing 47 information obtained so far from the sequencing run.
48
The second component is a dynamic (updatable) decision strategy that determines 49 in real time which fragments are worth sequencing and which should be rejected, based 50 on the initial portion of the fragment that has already been sequenced.
51
Objective Function
52
We propose a probabilistic framework to develop appropriate objective functions. The 53 basic idea is to consider the information gain that we expect a new read will provide, 54 i.e. its "expected benefit", given that we know the location and orientation of the 55 considered fragment along a reference genome. We assume that we know a reference 56 genome of N positions, over which reads (or partial reads) can be mapped. We do not 57 consider cases in which a reference genome is not available -possibly these could be 58 dealt with in future with real-time de novo assembly. We further assume that reads can 59 be unambiguously mapped onto the reference, which in turn ignores complications 60 deriving from large-scale mutational events such as rearrangements or copy number 61 variations; these types of events could also be included in future versions of the methods 62 (see Supplement).
63
The expected benefit of a candidate read is determined by the expected changes in 64 posterior genotype probability distributions (measured by the Kullback-Leibler 65 divergence [11] ), over positions that could be covered by the considered DNA fragment 66 if it were further sequenced. The current posterior probability of a genotype at each 
82
Positional Score
83
Here we discuss prior and posterior probabilities of different genotypes at a position of a 84 genome and define the score for the position, which will be used later to define the 85 expected score of a new read. We make a few simplifying assumptions to ease 86 presentation, and discuss extensions in the Supplement. Our first simplification is that 87
we assume that genetic diversity and sequencing errors occur only in the form of 88 substitutions (SNPs), while in the Supplement we discuss ways to account for indels and 89
rearrangements. We further assume that all positions in all reads are subject to 90 sequencing errors with the same probability, independently of the genotype or particular 91 read considered, and that sequencing errors across read positions are independent of one 92
another.
93
We denote the set of possible genotypes for the considered individual at the diploid genome (which we do not consider further), g ∈ G is an ordered pair of alleles
Similar definitions are possible also for polyploid genomes. In some 99 circumstances, ploidy might not be known a priori ; in such case, even more complex 100 definitions of G would be needed.
101
For each position i of a reference genome of length N , we denote π i (g) the 
106
When considering diploid sequenced genomes, we still assume a haploid reference 107 genome, with reference nucleotide at a given position denoted b R . In the case of a 108 diploid unphased genome being sequenced, we define π i ({b R , b R }) = 1 − θ, and 109 π i ({g, g}) = p homo θ/3 if g = b R , with p homo being the proportion of site differences from 110 a reference that are expected to be homozygous, and
We ignore the possibility of a heterozygous genome being sequenced with both 112 alleles different from the reference genome. These prior probability definitions also 113 ignore differences in mutation rates across nucleotides and genome positions and do not 114 use prior knowledge on SNP locations derived from the population; when available,
115
these aspects could however easily be included in the definition of π i (g).
116
Assume that at a given point in an experiment we have observed data D, containing 117 n reads mapping to position i. We denote by d j,i ∈ B the nucleotide observed in read j 118 that maps to reference position i. Then, the posterior probability of genotype g ∈ G at 119 position i and conditional on data D is
Z i (D) is a normalising constant, representing the likelihood of the data and ensuring
121
that the sum of the posteriors at site i is 1:
φ(d j,i |g) is the probability of calling base d j,i assuming genotype g at position i, and 123 will depend on the assumptions being made. For example, for a haploid genome in our 124 applications below we define
where e denotes the per-base sequencing error probability, meaning that any position along a read has a probability e of mis-representing the corresponding nucleotide of the 127 sequenced genome.
128
In the scenario of an unphased diploid genome we will instead consider 
The Kullback-Leibler (KL) divergence (or relative entropy [11] ) is a measure of how 130 different two distributions are. We want to use, as a measure of expected benefit, the
131
KL divergence between the posterior probability distributions before (f i (g|D)) and after 132 (f i (g|D )) observing a new read, as this tells us how much informative the new read is 133 about the genotype being sequenced. However, we don't know which base d j,i will be 134 the next one observed, so, instead, we average out over the possible values of d j,i .
135
P (d n+1,i |D), the probability of observing d n+1,i , is given by
February 8, 2020 7/31 S i , the current expected benefit of a new read at position i, is the expected KL divergence D KL between distributions f i (b|D) and f i (b|D ):
Defining the expected benefit in terms of KL divergence as above is a technique used in 137
Bayesian experimental design [12] , and is equivalent to defining it in terms of expected 138 reduction in Shannon entropy [13] of the posterior genotype probability distribution 139 after observing one more read base at the position considered. are, or course, modified by the priors for a given case: data that tend to confirm the 145 prior lead to decreased benefit expected from further reads; data that conflict with the 146 prior require more reads before relative certainty is achieved. 9.6 × 10
Some examples of scores S i and posteriors f i (g|D) for given counts (n A , n C , n G , n T ) of observed bases at position i. Here we assume that the reference genome has b R = A at this position, that we have no indels, and that θ = 0.01 and e = 0.06. For the first line, i.e. in the absence of read data, posteriors and priors are identical:
Read Utility
150
Now that we have defined a score S i for each individual genome position i, we need to 151 combine the scores of multiple positions into a scoring system for reads, assuming that 152 each read maps to a series of contiguous bases in the reference genome. For simplicity, 153 we describe our methods in the context of a circular chromosome, as typical for bacteria; 154
in the Supplement we relax this assumption and consider the case of one or more linear 155 chromosomes. We assume the circular genome has length N : fragments that extend is, the score of a forward-oriented read of length l starting at position i:
Similarly, for a reverse-oriented read we have Reference genome nucleotide at a position e Probability that a nuclotide is mis-read as a different nucleotide L(l)
Probability that a fragment has length l η
Number of values used to approximate
Time required to reject a fragment α Time required to acquire a new fragment µ Length required for mapping a fragment S Read Until strategy
Decision function of strategy S for a fragment starting at i with orientation o
Probability that a fragment starts at i and has orientation o Parameter Description π i (g) Prior probability of genotype g at position i f i (g|D) Posterior probability of genotype g at position i given data D φ(d|g)
Probability of a read containing character d for a position with sequence genotype g P (d|D) Posterior probability of sequencing character d given data D (depends also on prior)
Score, or benefit from additional sequencing, of position i S 
176
Finally, we define the expected benefit U i,1 of a read starting at position i, and 177 oriented in forward direction, as
This is, equivalently, the sum of the S j scores for all positions j ≥ i, each weighted by 179 the probability that the read will reach position j. Considering the cumulative
runs from 1 to max D L ), Eq. 10 can also be rewritten as
Reverse reads are dealt analogously, with expected score
Calculating function. This is also the approximation that we use in all applications considered here. 198
In the Supplement we also discuss an approximation using a piecewise linear function. 199
Assuming that ∼ CL (l) is a piecewise constant function means that there are values
As before, we have that 
The same approach can be used for efficiently calculating the scores U i,0 of reverse Using the read scores U i,1 and U i,0 defined in the previous sections, we now define our 210 'Read Until strategy' for deciding which reads to reject and which reads to fully 211 sequence, and show an efficient algorithm to find this strategy in practice. Our aim is to 212
optimise the rate of accumulation of 'expected benefit' over pores and over time. As 213 read scores U i,1 and U i,0 depend on genotype priors and on data D observed so far, our 214 strategy will do so as well. This means in particular that, as the sequencing run 215 progresses and D grows larger, the optimal strategy will also change; our aim in 216 practice will not only be to find such a strategy, but also to update it dynamically 217 during each sequencing run.
218
We assume that all fragments traverse pores at the same rate, independent of their 219
original genomic location and composition. To simplify exposition, we measure time in 220 units of fragment bases that could be read by a pore. For example, a time t is the time 221
taken by a pore to read through t bases when a fragment is already translocating We also assume that the initial part of a DNA fragment that is sequenced and used 229
to assess the genomic location of a DNA fragment has a constant length µ < min D L .
230
This means that, as a new DNA fragment enters a pore, we assume we always read its 231 first µ bases, and that these µ bases from the fragment are sufficient to map the its end, and so on. We say that S includes (i, o) if I S i,o = 1, and define |S|, the size of S, 243 to be the number of position-orientation pairs (i, o) at which I S i,o = 1. Good strategies 244 S are not known a priori, and our aim here is to determine an optimal (or close to optimal) strategy S given the current data D. We again assume that we have a circular 246 genome or chromosome and are interested in knowing the whole sequenced genotype.
247
The case of linear chromosome, the case of multiple chromosomes, and the case that one 248 is interested in knowing only part of the genome, are all presented in the Supplement. 249
Given the definitions above, the expected benefit of a DNA fragment of orientation o 250 starting at position i is 
Calculating the strategy-wise average time costt S and benefitŪ S requires knowing how often fragments from certain positions i and orientation o are captured by pores. In all our example applications, we assume that both orientations and all starting positions February 8, 2020 15/31 are equally likely. However, for generality here we use the notation F i,o to refer to the probability that a random fragment's first base maps on genome position i and its orientation is o (1 for forward and 0 for reverse as usual), so that o=1,0 N i=1 F i,o = 1. The average benefit per fragmentŪ S of strategy S then becomes
and its average fragment-wise costt S is
For the special case of uniform distribution of fragments, F i,o = 1/2N , eqs. 17 and
and
where
If nanopores are used for short amounts of time since a strategy S has been 257 calculated, benefit is expected to accumulate at rateŪ S /t S . In practice, we 258 continuously update the chosen strategy as more sequencing data is generated. To find 259 the current strategy S that maximises the expected benefit per unit timeŪ S /t S given 260 the sequencing data already generated, we need to find
We call our optimal strategy approach 'BOSS-RUNS', for Benefit-Optimizing 
. Strategy S σ is defined by setting I S σ ı = 1 for o 1 ) , . . . , (i σ , o σ ) and 0 otherwise, and it is the optimal strategy of size σ.
269
Starting with σ = 0, we successively increase σ, at each stage testing whether
to discover whether S σ+1 gives an improvement over S σ . Once we reach a value σ * 271 such that there is no further improvement, we have the optimal S = S σ * .
272
Simulations
273
To test the proposed BOSS-RUNS strategy and investigate its potential in a range of of µ is dependent on the efficiency of basecalling and mapping and µ = 500 is consistent 287 with our experiences with real time analysis using GPU basecalling [7] . Genetic This results in a realistic [14] average fragment length of about λ = 6,300 bp. In 293 practical applications, a decision strategy is not required for fragments shorter than µ. 294
Throughout the first set of scenarios simulated, we assume a circular bacterial 295 genome of size 4Mb:
296
• 'normal' scenario: uniform (unbiased) expected coverage and the whole genome is 297 considered of interest.
298
• 'sequencing bias' scenario: we simulate variation in the proportions and which sequencing bias is not known a priori.
306
• 'MLST' scenario: we assume that we are interested in sequencing only a small 307 fraction (0.25%) of the genome, consisting of 10 equally spaced loci each of 1 kb. 308
This scenario resembles the case in which one is interested in a multi-locus 309 sequence typing of a bacterial sample [15] .
310
• 'cgMLST' scenario: we assume that we are interested in sequencing one quarter of 311 the genome consisting of 100 equally spaced loci each of 10 kb. This scenario 312 resembles the case in which one is interested in a core-genome multi-locus 313 sequence typing [16] .
314
In a second set of simulations, we consider a genome made of 16 per-read basis and is not limited by these batch sizes.
335
Bacterial sequencing is then simulated up to a total pore time of 200,000,000
336
(corresponding to the time it would take one pore to read a 200 Mb fragment). For yeast 337 sequencing, we considered times up to 600,000,000. We consider four possible strategies: 338
• 'naive' strategy: all reads are always accepted, corresponding to a standard 339 sequencing run without Read Until.
340
• 'full BOSS-RUNS' strategy: our BOSS-RUNS strategy is updated every batch, or 341 after a threshold of time if batches arrive too quickly. This time threshold is 342 4,000,000 for bacterial genomes with batch size 4,000; 1,000,000 for bacterial 343 genomes with batch size 500; 12,000,000 for yeast genomes with batch size 4,000; 344 or 3,000,000 for yeast genomes with batch size 500. This threshold makes sure 345 that there is sufficient time to compute updates to the strategy.
346
• 'partial BOSS-RUNS' strategy: we sequence a genome using the initial Read Until 347 strategy (i.e. derived at the start of the experiment), but do not make updates to 348 that strategy for some time. We illustrate these strategies using updates only 
Results
363
Focusing Sequencing Efforts on Regions of Interest
364
A naive enrichment of specific regions of interest defined a priori by rejecting unwanted 365 reads has been previously demonstrated [5, 7, 8] . We began our simulations with a 366 similar goal, adding our refined BOSS-RUNS strategies to seek improvements in 367 performance over earlier approaches. We first focus on two specific scenarios, resembling 368 a bacterial MLST study ( 
Supplementary Figs 1 and 2). Minimum coverage is increased approximately 5-fold in
374
the MLST scenario (Fig 3A) , and about 2-fold in the cgMLST scenario (Fig 3C) . This 375
in turn leads to a dramatic reduction in the uncertainty of the reconstructed genome,
376
with BOSS-RUNS strategy requiring far less sequencing to achieve the same quality of 377 genome reconstruction than naive sequencing: about one quarter of the time in the MLST scenario (Fig 3B) although more than half in the cgMLST scenario (Fig 3D) .
379
In all our analyses, we simulated sequencing continuing for extended periods, to 380 enable observation of both the short-and long-term performance of each approach.
381
Indeed, BOSS-RUN strategies do seem to outperform naive sequencing in both the 382 short-and long-term. While our strategies lead to higher coverage over the regions of 383 interest than over the rest of the genome (Supplementary Figs 1C and 2C) , they do not 384 necessarily lead to higher coverage in these regions than a naive sequencing run
385
( Supplementary Fig 2A) -an important feature showing that our strategies can adapt 386 during a sequencing run to reject reads from regions of interest that have already 387 achieved sufficiently high coverage compared to other regions of interest.
388
In both MLST and cgMLST scenarios, partial BOSS-RUNS (activating updates to 389 the initial strategy only for the final 1 ⁄2 or 1 ⁄4 of the sequencing run) seems preferable to 390 updating the strategy from the start (full BOSS-RUNS; see Fig 3) . This might seem 391 counter-intuitive, but our strategy is optimized to gain the most benefit in the short 392 term, and so may reject fragments early on that later might be more useful. For currently average coverage might become regions with low coverage in the future, and so 396 rejecting reads from these regions might not be advantageous in the long term.
397
Compensating for Sequencing Biases
398
One promising potential application of our strategy is the possibility of compensating 399 for the inherent tendency of some genomic regions to be sequenced at higher coverage 400 than others, possibly due to GC content among other factors [18, 19] . This could deliver 401 a more homogeneous coverage, with the potential benefit of reducing genotype calling Each color summarizes 30 replicates, with upper, central and lower boundary lines representing respectively the 90th, 50th and 10th percentiles. Red and orange lines represent naive strategies (respectively with batches of 4,000 and 500 reads); blue and azure lines represent full BOSS-RUNS strategies (updates from the start; respectively with batches of 4,000 and 500 reads); dark and light green lines represent 1 ⁄2-BOSS-RUNS strategies (updates only done in the final half of the sequencing run; respectively with batches of 4,000 and 500 reads); dark and light purple lines represent 1 ⁄4-BOSS-RUNS strategies (updates only in the final 1 ⁄4 of the run; respectively with batches of 4,000 and 500 reads).
uncertainty and thus typically of lower coverage, can substantially increase the 409 minimum achieved coverage across the genome. While naive sequencing achieves a 410 minimum coverage of 1-3x by the end of this hypothetical experiment, our BOSS-RUNS 411 strategies achieve a minimum coverage of at least 4x ( Fig 4A) ; the full BOSS-RUNS 412 strategy, in particular, achieves a minimum coverage between 8-10x. Regions of low 413 coverage are also typically the ones with the highest uncertainty, and, as a consequence, 414
our strategies considerably decrease the number of errors in genome reconstruction.
415
While at the end of the simulated runs naive sequencing shows about 100 errors,
416
BOSS-RUNS strategies usually have less than one error (Fig 4B) . Furthermore, the full 417 BOSS-RUNS strategy is the fastest at achieving the mark of (e.g.) one error per 418 genome, reaching it while naive sequencing still has usually more than 1000 errors. In in particular, usually lead to the best results, up to almost doubling minimum coverage 446 (Fig 6E) . Overall, the benefits of all BOSS-RUNS strategies are consistent in the case of 447 yeast genome, probably because of their ability to increase coverage towards the ends of 448
chromosomes. In the case of a bacterial genome, running our full BOSS-RUNS strategy 449
consistently throughout a long sequencing run can be counter-productive, as many reads 450
are rejected early on that would have been more useful later (the strategy behaves One aspect that we do not model is the possibility that fragment rejections would 472 cause excessive pore blockage and thus loss of sequencing capacity [7] . More effort is 473 needed in this respect both on our modeling side and on an engineering side. Another 474 possible extension could be the modeling of variation in partial fragment length (µ),
475
acquisition time (α), and rejection time (ρ), each currently assumed to take a constant 476 time.
477
Our strategy works well on small genomes, for example for bacteria or yeast, but the NumPy package [20] , and as such benefits from good computational performance, in 482 the future further optimization could be possible by coding our methods in a fast,
483
compiled language such as C or C++. However, scaling our methods to the size of the 484 human genome might require re-thinking fundamental aspects of our strategy.
485
Another aspect that would benefit our strategy is the inclusion of more complex 486 mutational events, such as insertions and rearrangements (see Supplement). These 
